NTRB - Nutriband Inc

4.02
-0.230   -5.721%

Share volume: 22,454
Last Updated: 03-10-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$4.25
-0.23
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
43%
Profitability 35%
Dept financing 24%
Liquidity 74%
Performance 48%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.80%
1 Month
-6.73%
3 Months
-19.11%
6 Months
-41.99%
1 Year
-34.10%
2 Year
71.06%
Key data
Stock price
$4.02
P/E Ratio 
0.00
DAY RANGE
$4.02 - $4.28
EPS 
-$2.68
52 WEEK RANGE
$3.96 - $11.68
52 WEEK CHANGE
-$36.79
MARKET CAP 
75.068 M
YIELD 
N/A
SHARES OUTSTANDING 
12.175 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.70
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$15,540
AVERAGE 30 VOLUME 
$11,253
Company detail
CEO: Gareth R. Sheridan
Region: US
Website: nutriband.com
Employees: 10
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl system.

Recent news